Reuters: GlaxoSmithKline Launches $50M VC Fund
GlaxoSmithKline on Thursday announced a $50 million venture fund and said the fund's first investment was made in SetPoint Medical, which is working on implantable devices to treat inflammatory diseases, Reuters reported.
8 August 2013•2 mins read
